Jaume Giró, General Manager of the “La Caixa” Bank Foundation, and Manel Esteller, director of the Epigenetics and Cancer Biology Program of the Bellvitge Institute of Biomedical Research (IDIBELL), have presented today a pioneering study on epigenetic prediction of drug response to optimize cancer therapy in patients who no longer respond to standard treatments. The […]
The Direcció General de Recerca de la Secretaria d’Universitats i Recerca (Departament d’Empresa i Coneixement) has granted a project to Bellvitge Biomedical Research Institute (IDIBELL) for the optimization, adaptation, improvement of facilities and acquisition of technological equipment at IDIBELL because of the forthcoming integration of the Center for Regenerative Medicine in Barcelona (CMRB) in these spaces.
ERDF funds enable the incorporation of CMRB to IDIBELL’s facilities Read More »
Cognition and Brain Plasticity Unit of Barcelona Cognition and Brain Plasticity Unit of Barcelona
Brain plasticity in expert pianists depends on age of musical training onset Read More »
Paper Esteller M Genome Biology
Remote uncontrol of DNA in cancer: genome ”wormholes” Read More »
Genetics Porta-de-la-Riva M, Cerón J, Nature Medicine.
C. elegans as a model to study cancer, in Genetics and Nature Medicine journals Read More »
Article Esteller M Translational Psychiatry,
Discovered a common genetic basis for all dementias Read More »
Research groups led by Dr. Virginia Nunes and Dr. Manuel Palacin, UB professors and researchers from Bellvitge Biomedical Research Institute (IDIBELL) and Institute for Research in Biomedicine Barcelona (IRB Barcelona), respectively, at the same time responsible for the Ciber 730 and U731 units for Rare Diseases (CIBERER), have identified the AGT1/rBAT protein as a new
Researchers from the group of Aging and Cancer, led by Purificación Muñoz in the Institute of Biomedical Research of Bellvitge (IDIBELL) demonstrated that the cancer stem cell features change during the skin squamous cell carcinoma progression to generate highly aggressive and metastasis prone tumors. These results were recently published in Cancer Research journal. Squamous cell
